DG Health Children's Acetaminophen Recalled for Contaminated Excipient
Perrigo Company is recalling DG Health Children's Pain and Fever (acetaminophen) oral suspension because the product was manufactured with a contaminated excipient that was itself recalled by its supplier.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The source identifies this as an FDA Class II recall with a CGMP deviation involving a contaminated excipient. No illnesses or injuries are reported in the source text, and the hazard is manufacturing/control-based rather than an acute safety threat. This fits the Moderate category for manufacturing-related concerns without reported harm.
Plain-English summary
Perrigo Company PLC is recalling DG Health Children's Pain and Fever, a grape-flavored acetaminophen oral suspension (160 mg/5 mL) in 4 FL OZ (118 mL) bottles, distributed nationwide by Dolgencorp, LLC. The recall affects 16,992 bottles from batch 1CK1001 with an expiration date of 12/31/2022, identified by NDC 55910-251-26.
The recall was issued because the product was manufactured using a contaminated excipient that had been recalled by its supplier. This represents a manufacturing deviation from current good manufacturing practice (CGMP) standards.
Consumers who have purchased this product should stop use immediately and consult their healthcare provider with questions. The product should be discarded or returned to the place of purchase.
The recalled product
- Product
- DG HEALTH CHILDRENS PAIN AND FEVER (ACETAMINOPHEN)
- Brand
- DG HEALTH CHILDRENS PAIN AND FEVER
- Manufacturer
- Perrigo Company PLC
- Hazard
- contaminated-excipient
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1CK1001
- Exp 12/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27